Efficacy of ruxolitinib in a cohort of patients with myelofibrosis: A real-life observational study

Trial Profile

Efficacy of ruxolitinib in a cohort of patients with myelofibrosis: A real-life observational study

Completed
Phase of Trial: Phase IV

Latest Information Update: 06 Dec 2016

At a glance

  • Drugs Ruxolitinib (Primary)
  • Indications Myelofibrosis
  • Focus Therapeutic Use
  • Most Recent Events

    • 06 Dec 2016 Results (n=408; data between: Jun 2011 to Apr 2016) presented at the 58th Annual Meeting and Exposition of the American Society of Hematology
    • 19 Sep 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top